125 related articles for article (PubMed ID: 36396043)
1. Compound IMB-Z inhibits hepatitis B virus replication through increasing APOBEC3G expression and incorporation into viral nucleocapsids.
Hu J; Wang H; Yang L; Wu S; Li Y; Li Y; Li Z
J Glob Antimicrob Resist; 2022 Dec; 31():371-378. PubMed ID: 36396043
[TBL] [Abstract][Full Text] [Related]
2. APOBEC3G is a restriction factor of EV71 and mediator of IMB-Z antiviral activity.
Wang H; Zhong M; Li Y; Li K; Wu S; Guo T; Cen S; Jiang J; Li Z; Li Y
Antiviral Res; 2019 May; 165():23-33. PubMed ID: 30862444
[TBL] [Abstract][Full Text] [Related]
3. Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids.
Nguyen DH; Hu J
J Virol; 2008 Jul; 82(14):6852-61. PubMed ID: 18480459
[TBL] [Abstract][Full Text] [Related]
4. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.
Baumert TF; Rösler C; Malim MH; von Weizsäcker F
Hepatology; 2007 Sep; 46(3):682-9. PubMed ID: 17625792
[TBL] [Abstract][Full Text] [Related]
6. [Inhibition of hepatitis B and duck hepatitis B virus replication by APOBEC3G].
Lei YC; Ma T; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang DL
Zhonghua Gan Zang Bing Za Zhi; 2006 Oct; 14(10):738-41. PubMed ID: 17064466
[TBL] [Abstract][Full Text] [Related]
7. Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus.
Chen Z; Eggerman TL; Bocharov AV; Baranova IN; Vishnyakova TG; Kurlander R; Patterson AP
J Biol Chem; 2017 Aug; 292(32):13459-13479. PubMed ID: 28637869
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription.
Nair S; Zlotnick A
J Virol; 2018 May; 92(10):. PubMed ID: 29491156
[TBL] [Abstract][Full Text] [Related]
9. Deamination-independent inhibition of hepatitis B virus reverse transcription by APOBEC3G.
Nguyen DH; Gummuluru S; Hu J
J Virol; 2007 May; 81(9):4465-72. PubMed ID: 17314171
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatitis B virus replication by APOBEC3G in vitro and in vivo.
Lei YC; Hao YH; Zhang ZM; Tian YJ; Wang BJ; Yang Y; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Jul; 12(28):4492-7. PubMed ID: 16874860
[TBL] [Abstract][Full Text] [Related]
11. The potential role of APOBEC3G in limiting replication of hepatitis B virus.
Mohamadkhani A; Pourdadash A; Tayebi S; Estakhri A; Nazem H; Sotoudeh M; Poustchi H
Arab J Gastroenterol; 2012 Dec; 13(4):170-3. PubMed ID: 23432984
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Bioactivity of
Cui AL; Sun WF; Zhong ZJ; Jin J; Xue ST; Wu S; Li YH; Li ZR
Drug Des Devel Ther; 2020; 14():3723-3729. PubMed ID: 32982177
[TBL] [Abstract][Full Text] [Related]
13. APOBEC-mediated interference with hepadnavirus production.
Rösler C; Köck J; Kann M; Malim MH; Blum HE; Baumert TF; von Weizsäcker F
Hepatology; 2005 Aug; 42(2):301-9. PubMed ID: 16025511
[TBL] [Abstract][Full Text] [Related]
14. The innate antiviral factor APOBEC3G targets replication of measles, mumps and respiratory syncytial viruses.
Fehrholz M; Kendl S; Prifert C; Weissbrich B; Lemon K; Rennick L; Duprex PW; Rima BK; Koning FA; Holmes RK; Malim MH; Schneider-Schaulies J
J Gen Virol; 2012 Mar; 93(Pt 3):565-576. PubMed ID: 22170635
[TBL] [Abstract][Full Text] [Related]
15. APOBEC3G directly binds Hepatitis B virus core protein in cell and cell free systems.
Zhao D; Wang X; Lou G; Peng G; Li J; Zhu H; Chen F; Li S; Liu D; Chen Z; Yang Z
Virus Res; 2010 Aug; 151(2):213-9. PubMed ID: 20510315
[TBL] [Abstract][Full Text] [Related]
16. Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA.
Kitamura K; Wang Z; Chowdhury S; Simadu M; Koura M; Muramatsu M
PLoS Pathog; 2013; 9(5):e1003361. PubMed ID: 23696735
[TBL] [Abstract][Full Text] [Related]
17. Pregenomic RNA Launch Hepatitis B Virus Replication System Facilitates the Mechanistic Study of Antiviral Agents and Drug-Resistant Variants on Covalently Closed Circular DNA Synthesis.
Zhao Q; Chang J; Rijnbrand R; Lam AM; Sofia MJ; Cuconati A; Guo JT
J Virol; 2022 Dec; 96(24):e0115022. PubMed ID: 36448800
[TBL] [Abstract][Full Text] [Related]
18. Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation.
Yang L; Shi LP; Chen HJ; Tong XK; Wang GF; Zhang YM; Wang WL; Feng CL; He PL; Zhu FH; Hao YH; Wang BJ; Yang DL; Tang W; Nan FJ; Zuo JP
Acta Pharmacol Sin; 2014 Mar; 35(3):410-8. PubMed ID: 24487969
[TBL] [Abstract][Full Text] [Related]
19. A3G-induced mutations show a low prevalence and exhibit plus-strand regional distribution in hepatitis B virus DNA from patients with non-hepatocellular carcinoma (HCC) and HCC.
Ren F; Li W; Zhao S; Wang L; Wang Q; Li M; Xiang A; Guo Y
J Med Virol; 2021 Jun; 93(6):3672-3678. PubMed ID: 32779759
[TBL] [Abstract][Full Text] [Related]
20. APOBEC3G-Regulated Host Factors Interfere with Measles Virus Replication: Role of REDD1 and Mammalian TORC1 Inhibition.
Tiwarekar V; Wohlfahrt J; Fehrholz M; Scholz CJ; Kneitz S; Schneider-Schaulies J
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
